Cytiva Opens Cell Culture Center of Excellence
The new Massachusetts facility will strengthen Cytiva’s cell culture services.
Cytiva announced on Nov. 9, 2022 that it has opened a new Cell Culture Center of Excellence at its Marlborough, Massachusetts location. The center will provide expanded cell culture media development capabilities and new cell line development services, aligning with the company’s long term growth strategy.
The facility is 11,500 ft2 and will be run by experiences scientific teams and staff dedicated to transforming the future of process development, according to a company press release. Cytiva now provides a comprehensive approach to supporting customers working in early process development.
“Our Cell Culture Center of Excellence combines our scientific expertise with the latest technology. Our tailored solutions enable customers to bring a wide range of molecules from discovery to delivery – smarter and faster,” said Amanda Halford, vice-president, BioProcess, Cytiva, in the release.
Source: Cytiva
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
